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The metal ion chelators 4-hydroxy-5-methyl-3-pyridinecarboxylic acid (DQ5) and 1,5-dimethyl-4-
hydroxy-3-pyridinecarboxylic acid (DQ715) and Cu(II) and Zn(II) were investigated with the aim to
restore the homeostasis of the brain Cu(II) and Zn(II) in neurodegenerative diseases. The proton dissoci-
ation constants of the ligands, the stability constants, and the coordination modes of the metal complexes
formed were determined by pH-potentiometric, and spectral (UV–Vis and EPR or 1H NMR) methods. The
results show that in slightly acidic and neutral pH range mono and bis complexes are formed through
bidentate coordination of the ligands. The biological MTT-test reveals that the DQ715 ligand is able to
lower the cytotoxic effect of Cu(II) in human embryonic kidney HEK-293 cells. Our studies revealed, how-
ever, that none of the chelators were efﬁcient enough to withdraw these metal ions from the amyloid
aggregates.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Balanced homeostasis of metal ions is critical for the normal
function of the brain and is maintained within strict limits [1]. Dis-
harmony in metal ion homeostasis, especially that of iron and cop-
per will cause oxidative stress by increasing the formation of
reactive oxygen species (ROS) as superoxide ion, hydrogen perox-
ide, and hydroxyl radical, and thus damage many biomolecules
in the cells resulting in various neurodegenerative disorders [2].
It has been demonstrated that the increased brain Cu(II), Fe(III)
and also Zn(II) concentration in dyshomeostasis of these metal ions
inﬂuences the oligomerisation of b-amyloids in the Alzhei-
mer’brain [3]. The interactions of these metal ions with amyloid
precursor (APP) or amyloid b-peptide (Ab) can produce neurotoxic
H2O2. Then the reduced metal ions reacting with hydrogenperox-
ide will generate the extremely reactive hydroxyl radicals from
hydrogen peroxide in M(red) + H2O2?M(ox) + OH + OH reaction
leading to oxidative stress in brain [4–6]. Some selective ligands for
Cu(II) have been proposed as chelating agents for the therapy ofAD. The ﬁrst was clioquinol (CQ), which could chemically solubilize
Ab deposits in AD [7] likely through the interaction with copper.
Faller and coworkers suggested that a chelator with a conditional
dissociation constant (KD) of 10 pM (up to 100 nM range) for Cu(II)
should be sufﬁcient to retrieve copper completely from amyloid
deposits [8]. Other results show that an aB-crystallin chaperon
peptide prevents Cu(II)-induced aggregation of Ab1–40 due to selec-
tive Cu(II) binding ability in addition to preventing the amyloid ﬁ-
bril formation of Ab peptides [9]. The dissociation constant (KD) for
Cu(II) interaction with the chaperon peptide is in the lM range
[9,10].
The role of Zn this inert trace element is much less clear in the
neurodegenerative processes. Reported Zn(II) afﬁnity for Ab is sig-
niﬁcantly weaker than, that for Cu(II), values of dissociation con-
stants ranging between 1 and 20 lM [9]. However, the amyloid
aggregates contain relatively high concentration (mM) of zinc
[11]. Several attempts were made to obtain efﬁcient chelators with
moderate afﬁnity towards the metal ions such as Cu(II), Zn(II) or
Fe(III) that participate in amyloid aggregation, in order to prevent
the formation of plaques [12–14].
In previous papers [15–20] we reported the evaluation of sev-
eral hydroxypyridinecarboxylic acid derivatives (HPCs) as possible
chelating agents for Fe(III) and Al(III). To this aim, the Fe(III) and
Al(III) complexes formed with selected HPCs were studied. Now
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is well known that any Fe(III) and Al(III) chelator can complex
essential metal ions too in a chelation therapy regiment, thus caus-
ing toxic side effects due to metal ion deﬁciency. For example, zinc
deﬁciency problems are sometimes experienced in the deferiprone
therapy [21,22]. The evaluation of the complexation strength of
HPCs towards Cu(II) and Zn(II) can allow to predict the extent of
essential metal ion removal during the Fe(III) and Al(III) chelation
therapy. On the other hand, the very low cytotoxicity of HPCs, and
according to the Lipinski’s rule their low molecular mass, the rea-
sonable lipophilicity (which can allow the oral activity and the
easy blood brain barrier crossing) can represent important advan-
tages also for the employment of HPCs in the AD therapy. There-
fore, the evaluation of the complexation strength of the HPCs
towards Cu(II) and Zn(II) can allow to predict if these ligands can
remove copper and zinc from Ab, i.e. if they represent good candi-
dates also in the recovery of the disturbed brain metal ion homeo-
stasis in AD.
In the present paper we studied the Cu(II) and Zn(II) binding
afﬁnity of two HPCs derivatives: 4-hydroxy-5-methyl-3-pyridine-
carboxylic acid (DQ5) and 1,5-dimethyl-4-hydroxy-3-pyridine-
carboxylic acid (DQ715) (Scheme 1). Their coordination
properties in aqueous solution were determined by means of pH-
potentiometric titrations, UV–Vis and 1H NMR or EPR measure-
ments. The effects of DQ715 with Cu(II) chloride were evaluated
on cell viability of a combined way in human embryonic kidney
HEK-293 cells.
2. Experimental
2.1. Chemicals
DQ5 and DQ715 were synthesized as described in Ref [15]. Dou-
ble-distilled Milli-Q water was used for sample preparations. The
purity of the ligands was checked and the exact concentrations
of the stock solutions prepared were determined by potentiometric
titrations using the program SUPERQUAD for data evaluation [23]. The
pH-metric titrations were performed with 0.1 mol/dm3 KOH pre-
pared from KOH (Merck). The base was standardised against HCl
solutions prepared from 36% HCl (Merck). A ZnCl2 stock solution
was made by dissolution of anhydrous ZnCl2 in a known amount
of HCl, and its concentration was determined by complexometry
via ethylenediaminetetraacetate complexes, and gravimetrically
via the oxinate. The CuCl2 ion stock solutions were prepared from
CuCl22H2O (Reanal) dissolved in doubly distilled water, and the
concentration of the metal ion was determined gravimetrically
via precipitation of the oxinate.
2.2. pH-potentiometric studies
The pH-metric measurements for determining stability con-
stants of the proton and metal complexes of the ligands were car-
ried out in aqueous solution at an ionic strength of 0.2 mol/dm3 KCl
(Sigma Aldrich) at 25.0 ± 0.1 C. The titrations were performedN
OH
COOHH3C
H
N
OH
COOHH3C
CH3
Scheme 1. 4-Hydroxy-5-methyl-3-pyridinecarboxylic acid (DQ5) and 1,5-
dimethyl-4-hydroxy-3-pyridinecarboxylic acid (DQ715) shown in their fully pro-
tonated forms (H3L+ and H2L+, respectively).with a carbonate-free KOH solution of know concentration (ca.
0.1 mol/dm3). In order to keep the ionic strength constants KCl
has been added to the KOH solution to set the K+ concentration
0.2 mol/dm3. The HCl concentration was determined by potentio-
metric titrations using the Gran’s method [24]. An Orion 710A
pH-meter equipped with a Metrohm combined electrode (type
6.0234.1000) and a Metrohm 665 Dosimat burette was used for
the pH-metric measurements. The electrode system was calibrated
according to Irving et al. [25] (strong acid versus strong base; HCl
versus KOH titration) and therefore the pH-meter readings could
be converted into hydrogen ion concentration. The water ioniza-
tion constant, pKw calculated from strong acid-strong base titra-
tions was 13.76 ± 0.01 under the conditions employed. The
titrations were performed in the pH range 2–11 or until precipita-
tion occurred in the samples. The initial volume of the samples was
10 cm3 in case of DQ715 and 20 cm3 in case of DQ5 related titra-
tions. The ligand concentration was in the range of 0.5  103–
2  103 mol/dm3, and the metal ion to ligand ratios were 1:1,
1:2 and 1:4. The accepted ﬁtting between the experimental and
the calculated titration curves was always better than 0.01 cm3
and the uncertainties (3SD values) in the stability constants are gi-
ven in parentheses in Table 1. The samples were in all cases deox-
ygenated by bubbling puriﬁed argon for ca. 10 min before the
measurements, and argon was also passed through the solutions
during the titrations.
The protonation constants of the ligands were determined with
the computer program SUPERQUAD [23]. PSEQUAD [26] was used to
establish the stoichiometry of the complexes and to calculate their
stability constants (logb (MpLqHr). b (MpLqHr) is deﬁned for the
general equilibrium reaction pM + qL + rH  MpLqHr as b (MpLq-
Hr) = [MpLqHr]/[M]p[L]q[H]r, where M denotes the metal ion, L is
the completely deprotonated ligand molecule, and p, q and r are
the number of metal, ligand, and proton atoms, respectively.
According to the calibration protocol employed, the protonation
and stability constants are concentration constants which refer to
the given ionic strenght. The calculations were always made from
the experimental titration data measured in the absence of any
precipitate in the solution.
2.3. Spectrophotometric measurements
UV–Vis spectrophotometric measurements were performed in
aqueous solution at 25.0 ± 0.1 C on solutions containing the ligand
(either DQ715 or DQ5) at a 8.0  105 mol/dm3 concentration, and
themetal (either Cu(II) or Zn(II)) at the followingmetal to ligands ra-
tios: 0:1, 1:4, 1:2, 1:1. The pH range was from 2 to 11, and the ionic
strength was 0.20 mol/dm3 (KCl). The spectra were recorded under
argon atmosphere. A Hewlett Packard 8452A diode array spectro-
photometer was used to record the UV–Vis spectra in the interval
290–820 nm. The pathlength was 1 cm using quartz cuvettes. Pro-
tonation and stability constants and the individual spectra of the
species were calculated by the computer program PSEQUAD [26].
2.4. 1H NMR measurements
1H NMR studies were carried out on a Bruker Ultrashield 500
Plus instrument equipped with a 5 mm capillary NMR tube. In
the NMR measurements the magnetic ﬁeld was stabilised by lock-
ing with the 2D signal of the solvent. The sample temperature was
set to 25 ± 1 C during all data acquisitions. Chemical shifts are re-
ported in ppm (dH) from 4,4-dimethyl-4-silapentane-1-sulfonic
acid (DSS) as internal reference. The 1H NMR measurements were
performed withWATERGATE solvent suppression scheme. All sam-
ples were measured with the same experimental parameters, the
same spectrometer and the same probe. The relaxation delay, the
delay for binomial water suppression, and the number of scans,
Table 1
pKa values of DQ5 and DQ715, and stability constants of Cu(II) and Zn(II) complexes at 298 K in aqueous I = 0.2 mol/dm3(KCl).
DQ5 DQ715
Species pKa/logb Species pKa/logb
pH-pot UV–Vis pH-pot UV–Vis 1H NMR
H3L+ 0.23(6)* H2L+ 1 0.40(1)*
H2L 6.60(1) 6.61(2) HL 6.64(1) 6.63(1) 6.66(1)
HL >11
pH-pot UV–Vis pH-pot UV–Vis EPR
Cu(HL)+ 6.24(1) 6.39(3) CuL+ 6.27(1) 6.41(2) 6.47(2)
Cu(HL)2 11.33(5) 11.33(9) CuL2 10.95(2) 10.97(5) 11.02(2)
KD 3.1  107 mol/dm3 5.1  107 mol/dm3
pH-pot pH-pot 1H NMR
Zn(HL)+ 3.75(2) ZnL+ 3.77(2) 3.79(3)
Zn(HL)2 6.9(1) ZnL2 7.06(3) 6.96(7)
KD 7.5  104 mol/dm3 8.2  104 mol/dm3
KD = [M]free R[HxL]/R[MpHqLr] computed at pH 7.4 for cM = 2.5  105 mol/dm3, cL = 5.0  105 mol/dm3.
* Data are taken from Ref [15].
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DQ5 and DQ715 ligands and for Zn(II)–DQ715 system in 90:10
H2O/D2O mixtures at 1.1 mmol/dm3 (DQ5) and 2 mmol/dm3
(DQ715) ligand concentration. The Zn(II)–DQ715 ratios were 0:1,
1:1, 1:2 and 1:4. The ionic strength was adjusted to I = 0.2 mol/
dm3 with KCl in each sample. The pH of the solutions (pHobserved)
was measured with a pH-sensitive glass electrode (Metrohm
6.0234.100) and an Orion 710A pH meter, calibrated according to
the procedure described in the literature [25]). The equilibrium
constants and the limiting chemical shifts of the species formed
during protonation and Zn(II)-complexation were calculated by
PSEQUAD [26].DQ715
HL
N
CH3
OH
H3CN
CH3
OH
COOHH3C
H2L+
pK < 1
N
OH+
COOHH3C
CH3
DQ5
H2L
pK = 6.60
H3L+
pK < 1
N
H
OH
COOHH3C
N
H
OH
COO-H3C
N
OH+
COOHH3C
H
Scheme 2. Deprotonation st2.5. EPR measurements
All CW-EPR spectra were recorded with a BRUKER EleXsys E500
spectrometer (microwave frequency 9.7 GHz, microwave power
13 mW, modulation amplitude 5 G, modulation frequency
100 kHz). The isotropic EPR spectra were recorded at room temper-
ature in a circulating titration system. Nine EPR spectra were re-
corded at 1 mmol/dm3 CuCl2 and 2 mmol/dm3 DQ715 ligand
concentration, and six at 2 mmol/dm3 CuCl2 and 2 mmol/dm3
DQ715 ligand concentration, in the pH range 2–6 and 2–8.5,
respectively. At higher pH values precipitation was detected in
both cases. The ionic strength of 0.2 mol/dm3 were adjusted withN
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Fig. 1. Low-ﬁeld region of the 1H NMR spectra of the ligands at the indicated pH
values at T = 298 K (a, b) and T = 280 K (c) (cDQ5 = 1.1  103 mol/dm3, cDQ715 = 2 -
 103 mol/dm3 I = 0.2 mol/dm3(KCl)).
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which was measured with an Orion 710A pH-meter equipped with
a Metrohm 6.0234.100 glass elecrode. A Heidolph Pumpdrive 5101
peristaltic pump was used to circulate the solution from the titra-
tion pot through a capillary tube into the cavity of the instrument.
The titrations were carried out under nitrogen atmosphere. At var-
ious pH values, samples of 0.1 cm3 were taken, and frozen in liquid
nitrogen, and the CW-EPR spectra were recorded under the same
instrumental conditions as the room-temperature spectra de-
scribed above.
2.6. Evaluation of EPR spectra
The room-temperature EPR spectra were simulated simulta-
neously by the ‘‘two-dimensional’’ 2D_EPR program [27]. Each com-
ponent curve was described by the isotropic EPR parameters go,
Ao
Cu copper hyperﬁne coupling, and the relaxation parameters a,
b, c which deﬁne the linewidth through the equation rMI = a + b
MI + c MI2, where MI denotes the magnetic quantum number of
copper nucleus. The concentration of the complexes was varied
by ﬁtting their formation constants, b(MpLqHr) deﬁned above, in
the experimental description of pH-potentiometric studies.
The anisotropic spectra were analysed individually by the EPR
program [28], which gives the anisotropic EPR parameters (gx, gy,
gz, AxCu, AyCu, AzCu) and the orientation dependent linewidth
parameters).
For each spectrum, the noise-corrected regression parameter
(R) is derived from the average square deviation (SQD) between
the experimental and the calculated intensities. For the series of
spectra, the ﬁt is characterized by the overall regression coefﬁcient
R, calculated from the overall average SQD. The details of the sta-
tistical analysis were published previously [27]. Since a natural
CuCl2 was used for the measurements, all spectra were calculated
as the sum of the spectra of 63Cu and 65Cu weighted by their nat-
ural abundances. The copper coupling constants and the relaxation
parameters were obtained in ﬁeld units (Gauss = 104 T).
2.7. Determination of the distribution coefﬁcients
D values of the both ligands were determined by the traditional
shake ﬂask method [29,30] in n-octanol/buffered aqueous solution
at pH 7.4 (HEPES at 25.0 ± 0.2 C. Two parallel experiments were
performed for each sample. D of the carrier ligands was calculated
as the mean of [Absorbance (original solution)/Absorbance (aque-
ous phase after separation)  1] obtained in the region of
kmax ± 10 nm. The partition coeffeicient values (logP) for the neu-
tral forms of the ligands were calculated by taking into account
the appropriate proton dissociation constants.
The partition coefﬁcients of the neuatral forms of the ligands
(logP7.40), characterising their lipophilicity, were 0.11 for DQ715
and 0.46 for DQ5. These values represent only moderate
lipophilicity.
2.8. Cell cultures and cytotoxicity assay
Human Embryonic Kidney 293 (HEK-293) cell line was obtained
by ATCC, Rockville, MD. Cells were maintained in the logarithmic
phase at 37 C in a 5 % carbon dioxide atmosphere using the D-
MEM medium (Euroclone) containing 10% fetal calf serum (Euro-
clone, Milan, Italy), antibiotics (50 units cm3 penicillin and
50 lg cm3 streptomycin) and 2 mmol/dm3 L-glutamine. The
growth inhibitory effect toward HEK-293 cell line was evaluated
by means of MTT (tetrazolium salt reduction) assay [31]. Brieﬂy,
3  103 cells were seeded in 96-well microplates in growth medium
(0.1 cm3) and then incubated at 37 C in a 5% carbon dioxide atmo-
sphere. After 24 h, cells were treated with the compound to be stud-ied at the appropriate concentration. Triplicate cultures were
established for each treatment. After 24 h, each well was treated
with 0.01 cm3of a 5 mg cm3 MTT saline solution, and after follow-
ing 5 h of incubation, 0.1 cm3 of a sodium dodecylsulfate (SDS) solu-
tion in HCl (0.01 mol/dm3) were added. After overnight incubation
in the dark at 37 C in a 5% carbon dioxide atmosphere, the inhibi-
tion of cell growth induced by tested compounds was detected by
measuring the absorbance of each well at 570 nm using a Bio-Rad
680 microplate reader (Milan, Italy). Mean absorbance for each drug
dose was expressed as a percentage of the control untreated well
absorbance and plotted versus drug concentration. IC50 values repre-
sent the drug concentrations that reduced the mean absorbance at
570 nm to 50% of those in the untreated control wells.3. Results and discussion
3.1. Protonation constants
The acid–base properties of DQ5 and DQ715 were studied by
potentiometric and spectroscopic techniques. The protonation con-
stants presented here for these ligands are in good agreement with
those reported in previous papers, when the difference in ionic
strength is taken into account [15]. The pKa values also
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Fig. 3. Spectrophotometric absorbance curves of the Cu(II)–DQ715 system at
various pH values; cCu(II) = 4  105 mol/dm3, cDQ715 = 8  105 mol/dm3. The inset
shows the change in the absorbance the ﬁtted curves were calculated (with dashed
line) at 268 nm as function of the pH (I = 0.2 mol/dm3 (KCl), T = 298 K).
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stituents [15–17,32].
The protonation constants of DQ715, and DQ5 are listed in Ta-
ble 1. The signiﬁcant decrease in acidity of the carboxylic group
in the ligands (logK(COO) 6 1) can be mainly attributed to the
formation of an intramolecular hydrogen-bonding between the
COO and the phenolic OH, which favours the liberation of the ﬁrst
proton [15]. The signiﬁcantly lower second pKa in DQ715 than the
pKa of the phenolic OH in phenol or in salicylic acid has presumably
due to the possibility of the formation of a chinoid isomeric struc-
ture (Scheme 2). The existence of the chinoidic and aromatic iso-
mer forms of L is supported by 1H NMR measurements (Fig. 1a).
The exclusive formation of HL is seen at pH 2.11 and 4.50.
Increasing the pH the signals start to broaden and shifted. The
shifting can be explained by the deprotonation processes and the
broadening may support the assumption that two tautomeric
forms exist at these pH values. The chinoidic and the aromatic
forms are in a fast exchange with respect to the 1H NMR time scale
resulting in the broadened signals, however, at pH 10.35 the peaks
become sharp again suggesting that a single species, the aromatic
form is dominating again at this high pH.
An unequivocal assignment of the pK2 and pK3 values of DQ5 is
not possible either, because 4-hydroxypyridine derivatives can
adopt a chinoid electronic conﬁguration in tautomeric equilibrium
with the corresponding aromatic form. In case of DQ5 three HL
forms can exist (Scheme 2). The similar behavior could also be seen
in the spectra (Fig. 1b). The signals start to broaden and shift above
pH  5.4, and they practically disappear at 9.37. Probably at this
pH value the three different forms exist simultaneously also in fast
exchange. Increasing the pH the signals become sharp again. At pH
9.37 1H NMR spectrumwas recorded at 280 K too (Fig. 1c) showing
that one of the signals (d = 8.45 ppm) separated and became shar-
per while the signals of the other two isomers remained broad.
This spectrum may also support the coexistence of three forms in
the pH range 6.0–9.7.
The last pKa of DQ5 could not be accurately measured because it
is too high. Therefore, we disregarded the last proton dissociationa. Cu(II)–DQ5
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Fig. 2. Left: pH-potentiometric titration curves with the ﬁtted curves (with continuous
concentration ratios. Right: distribution diagrams of the most important Cu(II) species
DQ715; cCu(II) = 1  103 mol/dm3, cDQ715 = 2  103 mol/dm3 (I = 0.2 mol/dm3 (KCl), T =process and considered HL as the complex-forming species in the
equilibrium pM + qHL + rH =MpLqHr+q (for simplicity, charges will
be generally omitted from the formulae, except in the Tables). In
this way, more accurate formation constants were obtained,
although their numerical values differ by the value of the last
pKa from those calculated in the usual way for the equilibrium
pM + qL + rH = MpLqHr.
3.2. Cu(II)–DQ5 and Cu(II)–DQ715 systems
The chelating ability of DQ5 and DQ715 for Cu(II) was evaluated
on the basis of the cumulative formation constants of their com-
plexes, which were determined by potentiometric, UV–Vis, and
(in case of DQ715) by EPR measurements.
The pH-potentiometric titration curvesmeasured at 1:1, 1:2 and
1:4 metal ion-to-ligand concentration ratios, normalized to the0.0
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486 É. Sija et al. / Polyhedron 67 (2014) 481–489ligand concentration, are depicted in Fig. 2. (In all cases, strong acid
was added to the solution before titration in order to ensure acidic
conditions at the beginning of the measurements. The amount of
potassium hydroxide consumed by the strong acid has been sub-
tracted from the total OH consumption in Fig. 2). In the species dis-
tribution curves the predominant species for both ligands are mono
complexes. No other species could be assumed to improve the ﬁt of
the titration curves; e.g. no tris complex formation in measurable
concentration was indicated under the experimental conditions.
The shape of the analogous titration curves in both Cu(II)–li-
gand systems are similar until pH 5, indicating similar processes
in the solution. Complex formation starts at pH > 3. After a proton
loss from the carboxylic group, in the presence of the metal ion a
further deprotonation step is observed on the titration curves.
Although potentiometric data do not give any structural informa-
tion, it is reasonable to assume that the ligands coordinate to the
metal ion through the carboxylate oxygen and phenolate (biden-
tate chelation), and the pyridinic-N remains protonated in the
Cu–DQ5 complexes in the pH range studied. Accordingly, composi-
tion of the complex is Cu(HL), (while in the case of DQ715 as the
pyridine-N is methylated CuL). This result is similar to those ob-
tained for the complexes formed by 3-hydroxy-2-pyridinecarboxy-
lic acid and 4-hydroxy-3-pyridinecarboxylic acid with
aluminium(III) and iron(III) where the pyridinic-N also remains
protonated in the complexes at neutral pH [18].
The sharp break on the titration curve at ligand excess indicates
that precipitation occurs at pH  5 in the Cu(II)–DQ5 solutions.
Although the precipitate was not accurately analysed, presumably
it is the neutral bis complex, as when the complex was ﬁltered off
and redissolved in dilute HCl acid, signiﬁcant amount of the ligand
could be detected in the solution spectrophotometrically. It should
also be mentioned that in the samples with ligand excess precipita-
tion started at the same metal ion concentration when the concen-
tration of Cu(HL)2 reached the value of about 2.7  104 mol/dm3,
which is the concentration of the saturated solution of the complex
(as calculated from the stability constants listed in Table 1).
Note that in the case of DQ5 the monoprotonated species while
in the case of DQ715 the fully deprotonated catecholic L is the
complex forming ligand form.
The limited solubility of the ligands in water allowed to carry
out the pH-potentiometric titrations at a maximum of 2 mmol/
dm3 DQ715 and 1 mmol/dm3 DQ5 concentrations, and despite
the low solubility of the bis complex of DQ5, interpretation of
the potentiometric data leaves little doubt on the speciation model.
UV–Vis spectrophotometric measurements were performed to
conﬁrm the pH-potentiometric speciation result. Absorbance
curves of the Cu(II)–DQ715 system are shown in Fig. 3.
Fig. 3 shows the pH-dependent UV–Vis spectra of Cu(II)–DQ715
system and the change in the absorbance at 264 nm as function of
the pH at various metal-to-ligand ratios. Spectra are very similar to
those obtained for Cu(II)–DQ5 system (not shown). For DQ715 at
pH 2, the main peak at 252 nm is due to p?p⁄ transition of the
pyridinic ring, and by increasing the pH the deprotonation causes
a bathochromic shift till around 270 nm. The presence of Cu(II)
does not modify strongly the UV–Vis spectra of the ligands. Only
small modiﬁcations in the intensity and in the wavelength occur
as a function of pH. The complex formation was evidenced by mon-
itoring the absorption change in the wavelength range 230–
350 nm. At in this low concentration no other absorption band dis-
turbed the detected spectra. The stability constants of the different
complexes were determined from the pH-dependent spectra. For
both ligands, the UV–Vis spectra allowed the detection of two com-
plexes, CuL and CuL2 for DQ715, and CuLH and CuL2H2 for DQ5 and
the calculation of their stability constants. The UV–Vis logb values
agree well with those determined potentiometrically (see Table 1),thus conﬁrming the lack of the formation of any other species in
these metal–ligand systems.
EPR measurements were also carried out for Cu(II)–DQ715 solu-
tions in order to conﬁrm the pH-metric and spectrophotometric re-
sults and to obtain structural information on the complexes. The
isotropic and anisotropic EPR spectra could be explained by taking
into account the formation of 1:1 and1:2 complexes, beside the cop-
per(II)aqua complex (Fig. 4). The slight decrease of the g values in the
mono complex as compared with the g values of the aqua complex
indicates metal ion coordination by weak oxygen donors presum-
ably [COO, O] binding mode. Further decrease in g and increase
in A values occur in the bis complex indicating 2  [COO, O] coor-
dination. The coordination of the two ligands in cis–trans geometric
isomers could not be distinguished, possibly because of their very
close EPR parameters. Determination of both isotropic and aniso-
tropic EPR data of complexes CuL and CuL2 allowed to predict the
sign of their anisotropic copper hyperﬁne couplings (Ax and Ay)
(The determination of signs otherwise is a difﬁcult problem and re-dimensional’’ simulation.
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sign of these two values can change easily because of the similar
magnitudes but varying signs of the contributed Fermi contact term,
spin-dipolar coupling and the spin–orbit interaction). In this study
the measured isotropic hyperﬁne values have been compared with
those of the averaged values calculated by the equation Ao = (Ax + -
Ay + Az)/3 using different signs for Ax and Ay. (Negative sign for Az is
known for copper(II) complexes with elongated octahedral geome-
try). The signs giving the best accordance are shown in Table 2.
The good agreement between the measured and calculated values
presume also that the complex structure formed in solution is kept
upon freezing. Comparing the EPR parameters of CuL (go = 2.166
and Ao = 53 G) with those of copper(II)–ﬂuorosalicylic acid analogo-
ues (go = 2.179–2.186 and Ao = 35–38 G) [33], we can conclude
that much higher go values and lower Ao values could be detected
than for the different ﬂuorosalicylic complexes. This indicates a sig-
niﬁcantly higher ligand ﬁeld for DQ715 as comparedwith ﬂuorosal-
icylic acid, owing to the positive inductive effect of the pyridinic
nitrogen in contrast with the negative inductive effect of the ﬂuo-
rine. This agrees with the higher formation constants and the pre-
dominant formation of CuL in case of DQ715.
The formation constants and EPR parameters for the various
Cu(II) complexes are summarized in Tables 1 and 2.
The Cu(II) binding ability of both ligands are in the several hun-
dreds nM range (310 nM for DQ5 and 510 for DQ715). These values
means moderate binding ability are signiﬁcantly lower than that of
salicylic acid (13.4 lM) [34] butmuchhigher than that of deferiprone
(8.81 nM) [35]. Thismeans that theelectroniceffectof thepyridinic-N
(as compared to the aromatic benzene ring) in the ring increases the
donor strength of the O atoms, but the electronic structure of the
pyridinone ring offer an extra donor strength to the O atoms.
3.3. Zn(II)–DQ5 and Zn(II)–DQ715 systems
The complex formation constants of Zn(II)–DQ715 and Zn(II)–
DQ5 systems are listed in Table 1. In agreement with theTable 2
EPR parameters of components formed in Cu(II)–DQ715 system.
Isotropic EPR dataa Anisotropic EPR datab
go |Ao|/G g\ gx,gy g|| ||
gz
Cu2+ 2.194(1) 34.6(6) 2.079 2.412
CuL 2.166(1) 53.1(1) 2.069, 2.069 2.347
CuL2 2.149(1) 60.8(1) 2.066, 2.059 2.329
a Uncertainties (standard deviations) of the last digits are shown in parentheses. For t
and logb(HL) = 6.64 were used in the EPR analysis.
b The experimental errors were ± 0.001 for gx and gy and ± 0.0005 for gz, ±2 G for Ax a
c The signs of the experimental values were derived from a comparison of Ao,calc with
d |Ao,calc| = |(Ax + Ay + Az)/3|.
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Fig. 5. Distribution diagrams of the most important Zn(II) species in the presence of (a) D
cDQ715 = 2  103 mol/dm3(I = 0.2 mol/dm3 (KCl) T = 298 K).expectations only mononuclear complexes are formed in both
systems and the order of magnitude of the complex stability
obtained in this study is similar with the earlier ﬁndings reported
for the Zn(II)–2-hydroxynicotinic acid system [20]. This suggests
the same binding mode in the complexes formed in these systems,
i.e. a bidentate coordination of the carboxylate and hydroxyl
groups. Accordingly, the pyridinic-N remains protonated. Repre-
sentative species-distribution diagrams for typical Zn(II)–DQ715
and Zn(II)–DQ5 systems are depicted in Fig. 5. The metal complex
speciation in these systems do not differ considerably from each
other. It can be seen that the complexation begins at pH 3.5 with
the monocomplex. The bis complex becomes predominant above
pH 6. No evidence was found for the presence of any tris-complex
in the experimental conditions applied. For both Zn(II)–DQ715 and
Zn(II)–DQ5 systems, the pH interval examined in the potentiomet-
ric and 1H NMR measurements was limited because of early
precipitation of solid compounds. Precipitation occurred at
pH  8 and the appearrance of the precipitate suggest that it is
Zn(OH)2.
To support the potentiometric data, 1H NMR spectra were re-
corded in the presence of DQ715 at various pH values in H2O/
D2O solution at 1:0, 1:1, 1:2, and 1:4 metal-to-ligand ratios. Due
to the formation of the kinetically labile Zn(II) complexes, the posi-
tion but not the number and multiplicity of the NMR signals,
change as a function of pH. Stability constants of the complexes
were calculated from the extent of shifts of the signals by the PSE-
QUAD computer program. Results are very similar to those ob-
tained from pH-potentiometry (Table 1). Fig. 6 shows the
measured and calculated chemical shifts of the N–CH–C–COO as
a function of pH.
The Zn(II)–ligand complex formation was monitored by UV–Vis
spectrophotometric measurements too, but suitable UV–Vis spec-
tra could not be obtained because of the slight changes in the
absorption due to the low level of complexes formation with both
DQ5 and DQ715.Calculated isotropic EPR data
A\/G Ax, Ay/Gc A|| ||/G Az/G go,calc |Ao,calc|d/G
8.0 116.0 2.190 37.5
12.0, 12.0 147.0 2.161 53.2
8.1, 15.9 150.4 2.151 62.0
he proton complexes the pH-potentiometric formation constants logb(H2L+) = 7.64
nd Ay and ±1 G for Az.
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Fig. 6. Calculated and experimental 1H NMR shifts of the of N–CH–C–COO hydrogen
of DQ715 as a function of the pH in Zn(II)–DQ715 system (cDQ715 = 2  103 mol/
dm3 I = 0.2 M (KCl) T = 298 K).
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Fig. 7. Cytotoxicity proﬁle of CuCl2 and DQ715. HEK-293 cells were treated for 24 h
with increasing concentrations of CuCl2 (d) or DQ715 (s). Cytotoxicity was
evaluated by the MTT test. IC50 values were calculated by four parameter logistic
model (P < 0.05). Values are shown as the means (±SD) of ﬁve independent
experiments.
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Fig. 8. Effect of Cu(II) and DQ715 combined treatment. HEK-293 cells were treated
for 24 h with 0.15 mmol/dm3 of CuCl2 and then washed twice with PBS, and re-
incubated with fresh complete medium (black) or medium added with increasing
concentration of DQ715 (white), for further 24 h before MTT determination. Values
are shown as the means (±SD) of ﬁve independent experiments.
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HEK-293 human embryonic kidney cells were tested for their
sensitivity to Cu(II) (as CuCl2)-chloride and DQ715. Cells were trea-
ted for 24 h with increasing concentrations of CuCl2 and DQ715,
and cell viability was determined using the MTT test. Results are
reported in Fig. 7.As previously described [15], DQ715 proved to be hardly effec-
tive in decreasing cell viability, with an IC50 value of 1.4 mmol/
dm3. Conversely, IC50 calculated with CuCl2 was 0.15 mmol/dm3.
In order to study the effect of DQ715 in Cu(II) overload, HEK-
293 cells were pre-treated with 0.15 mmol/dm3 CuCl2 for 24 h
and further challenged with increasing concentrations (0.0–
0.7 mmol/dm3) of DQ715 for additional 24 h treatment. Fig. 8
shows the results obtained with MTT test. Co-treatment of HEK-
293 cell with DQ715 and CuCl2 determined a DQ715 dose-depen-
dent decrease of copper salt cytotoxicity, supporting the hypothe-
sis that DQ715 can reduce the copper induced antiproliferative
effect. Unfortunately DQ5 could not be studied because of the low-
er solubility of the compound.4. Conclusions
The chemical interactions between the metals Zn(II) and Cu(II)
and the ligands DQ715 and DQ5 have been investigated. The spe-
ciations are very similar, as only mononuclear mono and bis com-
plexes are detected in solution. The two ligands have a similar
metal binding ability towards Zn(II) and Cu(II). They are typical
hard ligands and therefore form weaker complexes with Zn(II)
and Cu(II) than with Fe(III) and Al(III) [15]. DQ715 forms slightly
weaker complexes than DQ5 due to the N-methyl substitution of
the pyridine ring which increases the hard character of the chela-
tor. To compare the metal binding strength of the ligands at phys-
iological pH, the KD values have been calculated for the complexes
at pH 7.4. The values obtained are in the mM range for the Zn(II)
complexes, i.e.the Zn(II) binding afﬁnity of both ligands is rather
low. Therefore the ligands can not have a positive inﬂuence on
the zinc homeostasis, i.e. DQ5 and DQ715 are expected to hardly
restore or remove only a small amount of zinc. However, this
low afﬁnity may be important if DQ5 and DQ715 is going to be
used as Fe or Al chelators, because zinc deﬁciency problems are
sometimes experienced in hard metal chelation therapy (e.g. for
deferiprone [18,19]). DQ5 and DQ715 are expected to cause no zinc
deﬁciency problem.
The afﬁnity of the ligands for Cu(II) is higher than for Zn(II). The
KD values are several hundred of nanomolar for both ligands. The
optimal KD values reported in the literature for Cu(Ab) range from
10 pM to 100 nM [8]. In any case it appears that DQ5 and DQ715
cannot retrieve Cu(II) from the amyloid aggregates. However, the
strength of the interactions with Cu(II) can be enough to bind the
copper(II) excess in the cells and protect them from the copper-in-
duced redox processes, which would generate ROS species. This
protection might explain why the Cu(II)-treated cells showed high-
er viability in the presence of DQ715. This protecting effect has
been evaluated also in the presence of Fe(III), and in that case
the enhanced effect was attributed to metal chelation [15]. The
acute and chronic Cu(II) toxicity can result in Cu(II)-induced oxida-
tive damage that has been implicated in disorders associated with
abnormal copper metabolism, liver disease and severe neurological
defects. Therefore, although the ligand is not a suitable chelator for
Cu(II) to remove this ion from the beta-amyloid proteins, it appears
suitable to protect the cells in some extent from the Fe(III) and
Cu(II) related oxidative stress, which may be involved in neurode-
generative disorders, like Alzheimer’s disease.Acknowledgements
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